Respiratory Infections News

Researchers observed a significant reduction in antibiotic prescriptions among pediatric primary care centers in Pennsylvania and New Jersey after the start of the COVID-19 pandemic.

Pfizer and BioNTech said Thursday that they have submitted a request to the FDA for an emergency use authorization of their COVID-19 vaccine in children aged 5 to 11 years.

The AMA has announced provisional CPT vaccine and administration codes for the Pfizer-BioNTech pediatric COVID-19 vaccine.

WHO on Wednesday published a clinical case definition of long COVID that includes 12 domains and 88 words.

The effectiveness of the Pfizer-BioNTech vaccine against any SARS-CoV-2 infection was about 20% among patients in Qatar 5 to 7 months after administration of the second dose, a study in The New England Journal of Medicine showed.

The FDA issued an emergency use authorization for a rapid COVID-19 test that it said could dramatically increase at-home testing capacity in the United States.

Johnson & Johnson said Tuesday that it has asked the FDA to authorize a booster dose of its one-shot COVID-19 vaccine for people aged 18 years or older.

Research to develop successful vaccines to help slow the spread of SARS-CoV-2 has taken place very publicly and at a historically fast pace.

Researchers at IDWeek reported more promising news about nirsevimab, an investigational single-dose monoclonal antibody that has previously been shown to protect preterm infants against respiratory syncytial virus.

The PROVENT study demonstrated that AstraZeneca’s AZD7442 monoclonal antibody cocktail significantly reduced the risk for developing symptomatic COVID-19.